Clinical Trial Update: A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to evaluate a topical drug for plaque psoriasis (psoriasis vulgaris); the trial completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Pfizer topical psoriasis agent

Snippet

Sponsor: Pfizer | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED | Results posted: 2016-06-09